FindTrial
Sign In

BAT ( balloon assisted shuttle technology ) technology and stent thrombectomy in the treatment of acute ischemic stroke on the basis of atherosclerosis Comparison of the efficacy of large vessel occlusion: a single-center, prospective, randomized controlled trial

BAT ( balloon assisted shuttle technology ) technology and stent thrombectomy in the treatment of acute ischemic stroke on the basis of atherosclerosis Comparison of the efficacy of large vessel occlusion: a single-center, prospective, randomized controlled trial - BAT ( balloon assisted shuttle technology ) technology and stent thrombectomy in the treatment of acute ischemic stroke on the basis of atherosclerosis Comparison of the efficacy of large vessel occlusion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400085083
Enrollment
Unknown
Registered
2024-05-30
Start date
2024-06-01
Completion date
Unknown
Last updated
2024-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute ischemic stroke

Interventions

BAT group:Patients who met the inclusion criteria and exclusion criteria and were predicted to have atherosclerotic acute large vessel occlusion were randomly assigned to the BAT technique group using
Stent thrombectomy group: Patients who met the inclusion criteria and exclusion criteria and were predicted to have atherosclerotic acute large vessel occlusion were randomly assigned to the stent thr

Sponsors

Dongguan Hospital of Guangzhou University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: ( 1 ) Age = 18 years ; ( 2 ) Clinical diagnosis of acute ischemic stroke ; ( 3 ) Within 24 hours of onset, including Wake-up stroke or non-witness stroke patients ; the timing of the onset of symptoms LKW ( Last Known Well, LKW ) ; ( 4 ) NIHSS score : 6-25 points ; ( 5 ) NCCT / DWI-MRI ASPECTS = 6 ; ( 6 ) CTA or MRA confirmed intracranial internal carotid artery, middle cerebral artery M1, M2 segment, basilar artery, vertebral artery V4 occlusion ; ( 7 ) BAT technology is preferred as the main strategy to open blood vessels ; ( 8 ) Sign the informed consent of surgery ;

Exclusion criteria

Exclusion criteria: ( 1 ) Patients with coagulation dysfunction ( INR > 1.7 ) ; ( 2 ) Glomerular filtration rate was 220 mol / L ( 2.5 mg / dl ) in patients with severe renal insufficiency. ) patients ; ( 3 ) multiple organ failure ; ( 4 ) patients with cardiogenic embolism ; ( 5 ) Preoperative CT or MR confirmed cerebral hemorrhage ; ( 6 ) Patients with severe contrast agent allergy ; ( 7 ) Patients with any active bleeding or recent history of bleeding in the past month ; ( 8 ) patients with mRS score = 3 before onset ; ( 9 ) pregnant or lactating women ; ( 10 ) platelet < 50 × 10 ^ 9 / L ; ( 11 ) Participate in other intervention experiments ; ( 12 ) Investigators believe that it is not suitable to participate in this study or may cause significant risks to patients ( such as mental illness, cognitive or emotional disorders that cannot be understood and / or subject to research procedures and / or follow-up ).

Design outcomes

Primary

MeasureTime frame
Modified Rankin Scale, 0-2 points ratio;—

Secondary

MeasureTime frame
NIHSS Scale;EQ-SD-5L Scale;—

Countries

China

Contacts

Public ContactLiaobin

Dongguan Hospital of Guangzhou University of Traditional Chinese Medicine

liaobin32@163.com+86 137 1277 9832

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026